MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    FGF14 repeat expansions: Case series of adult-onset cerebellar ataxia patients from Serbia

    A. Milovanović, NT. Dragašević Mišković, M. Borsche, A. Westenberger, N. Brueggemann, M. Svetel, I. Petrović, VS. Kostić, K. Lohmann (Belgrade, Serbia)

    Objective: The aim of this study was to investigate the presence of pathogenic repeat expansion in the FGF14 gene in patients with adult-onset cerebellar ataxia…
  • 2023 International Congress

    Measures of trancranial magnetic evoked potentials for prediction of response to ventriculoparitoneal shunt In normal pressure hydrocephalus

    T. Davidy, S. Anis, A. Sominski, J. Zauberman, T. Fay-Karmon, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: Assess the utility of an EEG-TMS-based evaluation for prediction of response to ventriculoperitoneal shunt (VPS) in normal pressure hydrocephalus (NPH). Background: VPS is the…
  • 2023 International Congress

    Drug-induced Parkinsonism and nonmotor symptoms: a case of gustatory rhinorrhea

    S. Casanova, A. Cabral, M. Branco (Vila Nova Gaia, Portugal)

    Objective: We aim to emphasize the relevance of contemplating nonmotor symptoms as possible features of drug-induced parkinsonism, and the utmost importance of further investigation in…
  • 2023 International Congress

    Gemini digital twins identified neuro-common and disease-specific drivers of rate of change in NfL in Huntington’s disease, Parkinson disease and Alzheimer disease

    X. Shen, S. Sathe, L. Sun, P. Ashrap, K. Johnson, S. Sukhram, S. Reddy, S. Shin, J. Latourelle, C. Sampaio (Somerville, USA)

    Objective: Identify common and disease specific molecular drivers of rate of change in Neurofilament light (NfL) in Huntington’s disease (HD), Parkinson disease (PD) and Alzheimer…
  • 2023 International Congress

    A case of idiopathic lower limb dystonia treated with combined use of botulinum toxin type A and phenol nerve block

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: Here we report a case of focal LLD successfully treated with combined botulinum neurotoxin type A (BoNTA) and Nerve block (NB). Background: Among focal dystonias,…
  • 2023 International Congress

    The predictive potential of circular walking in prodromal Parkinson’s disease

    ME. Micó-Amigo, I. Kingma, S. Heinzel, S. Solbrig, MA. Hobert, M. Elshehabi, K. Brockmann, FG. Metzger, R. van Lummel, D. Berg, W. Maetzler, JH. van Dieen (Edinburgh, United Kingdom)

    Objective: This study aims to provide quantitative markers of prodromal motor symptoms of idiopathic Parkinson’s disease (PD) from circular walking assessment with a single body-fixed-sensor.…
  • 2023 International Congress

    A digital differential diagnostic aid for Parkinson’s disease and other tremor disorders

    C. Papasavvas, D. Bramwell, R. Zietsma, A. Deutschlander, R. Walker (Edinburgh, United Kingdom)

    Objective: To validate an AI-enhanced decision support tool to assist health care professionals (HCP) in distinguishing between patients with Parkinson’s disease (PD) and those with…
  • 2023 International Congress

    Practice and outcome variation across Parkinson’s Foundation Centers of Excellence

    C. Marras, N. Dahodwala, J. Beck, A. Naito, Z. Meyer, A. Ramirez-Zamora, M. Neault, M. Rose Rafferty, T. Davis, H. Liu (Toronto, Canada)

    Objective: To identify center-level variations in Parkinson’s disease (PD) treatment practices and outcomes, and the relationship between treatment and outcomes to inform best practices Background:…
  • 2023 International Congress

    Trial site factor in Parkinson’s disease (PD) diary non-compliance

    P. Reksoprodjo (Prague, Czech Republic)

    Objective: In this analysis, we wanted to explore if PD diary non-compliance is distributed randomly in the dataset or if it has a tendency to…
  • 2023 International Congress

    Non-invasive Vagus Nerve Stimulation Alters Molecular Markers in Parkinson’s Disease Patients with Freezing of Gait

    R. Banerjee, B. Mondal, S. Choudhury, A. Roy, K. Chatterjee, P. Basu, S. Baker, M. Baker, H. Kumar (Kolkata, India)

    Objective: To investigate molecular mechanisms underlying non-invasive vagus nerve stimulation (nVNS) in Parkinson’s disease (PD) patients with freezing of gait (FOG). Background: FOG remains one…
  • « Previous Page
  • 1
  • …
  • 321
  • 322
  • 323
  • 324
  • 325
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley